| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |